Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 314M | 269M | 271M | 256M | 240M | 235M |
| Cost of revenue | 97M | 85M | 87M | 83M | 81M | 80M |
| Research and development | 18M | 12M | 13M | 11M | 11M | 16M |
| Selling, general and administrative | 31M | 32M | 29M | 23M | 23M | 40M |
| Operating expenses | 233M | 208M | 206M | 191M | 213M | 226M |
| Operating income | 80M | 60M | 65M | 65M | 27M | 8M |
| Pre-tax income | 60M | 43M | 47M | 46M | 9M | −42M |
| Income tax | 17M | 12M | 14M | 17M | 3M | −15M |
| Net income | 43M | 31M | 32M | 29M | 5M | −28M |
| Earnings per share | 0.23 | 0.18 | 0.19 | 0.17 | 0.03 | −0.21 |
| Earnings per share, diluted | 0.22 | 0.17 | 0.18 | 0.16 | 0.03 | −0.21 |
| Weighted average shares | 192M | 174M | 173M | 172M | 172M | 134M |
| Weighted average shares, diluted | 195M | 181M | 182M | 181M | 176M | 134M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 34M | 61M | 421M | 290M | 224M | 182M | 127M | 68M |
| Receivables | 173M | 177M | 146M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 85M | — | — | 64M | — | — |
| Depreciation and amortisation | 41M | 33M | 33M | 33M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 143M |
| 147M |
| 145M |
| 138M |
| 148M |
| Current assets | 387M | 308M | 614M | 524M | 441M | 371M | 305M | 271M |
| Goodwill | 4.01B | 4.02B | 3.02B | 3.02B | 3.02B | 3.02B | 3.02B | 3.03B |
| Total assets | 5.84B | 5.79B | 4.75B | 4.68B | 4.62B | 4.58B | 4.54B | 4.57B |
| Current liabilities | 220M | 218M | 158M | 153M | 141M | 146M | 133M | 126M |
| Short-term debt | 14M | 14M | 12M | 12M | 12M | 12M | 13M | 13M |
| Long-term debt | 1.46B | 1.46B | 1.21B | 1.22B | 1.22B | 1.22B | 1.22B | 1.33B |
| Total liabilities | 1.90B | 1.91B | 1.52B | 1.50B | 1.49B | 1.50B | 1.49B | 1.62B |
| Equity | 3.94B | 3.88B | 3.22B | 3.17B | 3.13B | 3.08B | 3.05B | 2.95B |
| Shares outstanding | 192M | 192M | 175M | 174M | 173M | 172M | 172M | 167M |
| Shares issued | 192M | 192M | 175M | 174M | 173M | 172M | 172M | 167M |
| 60M |
| 44M |
| Share-based compensation | 11M | — | — | 7M | — | — |
| Capital expenditure | 15M | — | — | 5M | — | — |
| Investing cash flow | −112M | — | — | −30M | — | — |
| Financing cash flow | 13M | — | — | 11M | — | — |